Intensity Therapeutics (INTS) executive Wesolowski acquired 1,000 shares at $4.00
Insider transactions reported
John M Wesolowski (Principal Accounting Officer at Intensity Therapeutics Inc., INTS) reported that they acquired 1,000 shares at $4.00 on Jun 5, 2024. After these transactions the filing shows 6,691 shares held directly.
- Reporting person
- Wesolowski John M
- Role
- Principal Accounting Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 5, 2024 | Exercise or conversion of a derivative (M) | Common Stock, $0.0001 Par Value1 | +1,000 | $4.00 | $4,000 | 6,691 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 5, 2024 | Exercise or conversion of a derivative (M) | Stock Option (right to buy Common Stock)On 1,000 Common Stock2 | -1,000 | - | - | 14,000 direct |
Holdings before and after
- Common Stock, $0.0001 Par Value: 5,691 to 6,691 direct
- Stock Option (right to buy Common Stock): 15,000 to 14,000 direct
Footnotes from the filing
- 1. Due to an inadvertent error, the Form 3 filed by the Reporting Person on June 29, 2023 incorrectly reported the amount of securities beneficially owned. This inadvertent error caused the amount of securities beneficially owned to be understated by 691 shares. The new amount reported in Column 5 reports the correct amount of securities beneficially owned following the reported transaction.
- 2. This option is fully vested and exercisable as of March 27, 2021.
Transaction codes in this filing
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Wesolowski report in this INTS Form 4?
John M Wesolowski (Principal Accounting Officer at Intensity Therapeutics Inc., INTS) reported that they acquired 1,000 shares at $4.00 on Jun 5, 2024. After these transactions the filing shows 6,691 shares held directly.
How many INTS shares does Wesolowski hold after this filing?
The filing shows 6,691 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code M mean on an SEC Form 4?
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
Historical context for INTS
Earlier insider filings at INTS
- May 15, 2024SEC Form 4 filed by Dubin Thomas I H
- Mar 7, 2024SEC Form 4 filed by Wesolowski John M
- Mar 7, 2024SEC Form 4 filed by Leahy Emer
- Mar 7, 2024SEC Form 4 filed by Goldberg Mark A
- Mar 7, 2024SEC Form 4 filed by Donovan Daniel
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2023
Follow INTS and get a push notification the moment its next story breaks.